Making a Killing: The Deadly Implications of the Counterfeit Drug TradeCounterfeit pharmaceuticals kill hundreds of thousands of people every year. Although most pervasive in poor countries, counterfeit drug trafficking is a worrying new phenomenon in the developed world. Payoffs for counterfeiters are high--the global market amounts to billions of dollars per year--and potential punishment is slight compared to the strict penalties facing narcotics dealers. From Internet pharmacies frequented by American consumers to the back streets of New Delhi, counterfeit drug trafficking is a complex, deadly, and increasingly lucrative industry that is becoming an attractive arena for organized crime. In this groundbreaking study, Roger Bate traces pharmaceutical counterfeiting around the world, from developed nations, where counterfeits often target "lifestyle" drugs such as Viagra, to developing countries, where counterfeiters favor therapeutic medicines such as antimalarials and antibiotics. Enforcement in developing nations is hampered by inadequate education, feeble regulation, and sluggish policing of existing laws. The United States is struggling to thwart an insidious Internet market. Making a Killing: The Deadly Implications of the Counterfeit Drug Trade champions greater cooperation between wealthy and poor nations to quash the trade in counterfeit pharmaceuticals. Bate calls for fortified policing resources, harsher penalties for counterfeiters, widespread public education, and commonsense consumer vigilance against this danger. Western policymakers must act immediately to quell the deadly counterfeit market in developing countries--and to ensure the integrity of their products at home. |
Contents
COUNTERFEITING TODAY | 8 |
HOW AND WHY DOES COUNTERFEITING OCCUR? | 25 |
STOPPING THE FAKERS | 39 |
Copyright | |
6 other sections not shown
Common terms and phrases
accessed March 17 According active Africa agencies American antimalarials approved Association authorities Chairman chapter China Chinese combat companies consumers corruption counterfeit drugs Counterfeit Medicines criminal customs Dangerous developing countries developing world distribution Drug Administration Economic effective enforcement especially estimated European example export fake drugs February Fellow Food and Drug Global IMPACT important improve increased India industry ingredients intellectual property International Internet January Journal July lack legitimate less levels licenses manufacturing Medical million Nigeria October officials operations packaging parallel trade patents percent pharma pharmaceutical pharmaceutical companies pharmacies pharmacists Policy problem property rights protect regulation regulatory remain reports Representative requirements Research Resident Scholar Roger Bate safety selling sold standards substandard drugs supply chain tariffs testing trade United Visiting weak wholesalers World Health Organization